(lp0
S'Antares Pharma Inc. and Nivalis Therapeutics Inc. Show Resiliency as They Snap ... Yahoo Finance - Mar 15, 2017 Antares stock has been on a steady rise for the past year. The company develops and manufactures pressure-assisted injector devices that allow patients to self-inject prescription drugs.'
p1
aS'Market View: Checking on the Technicals for Antares Pharma, Inc.  The Standard - 15 hours ago Tracking shares of Antares Pharma, Inc. , the company has a current EV  of 415422. Enterprise Value measures the total value of a specific company.Stocks to Track: Antares Pharma, Inc.  , Gildan Activewear, Inc ... - NYSE Journal Numbers in Focus for Antares Pharma, Inc.  - Davidson Register'
p2
aS'Earnings Growth Research: Antares Pharma, Inc. , McCormick &amp; Company ... USA Commerce Daily - 23 hours ago Shares of Antares Pharma, Inc.  are making a strong comeback as they have jumped 295.71% since bottoming out at $0.7 on Mar. 28, 2016.'
p3
aS'Antares Pharma: Realistic Expectations Seeking Alpha - Feb 1, 2017 This article represents an extension to an SA article published December 30, titled &quot;Antares Pharma: Drug Delivery to Multiple Fronts of Profitability&quot;.'
p4
aS'Antares Pharma: Drug Delivery To Multiple Fronts Of Profitability Seeking Alpha - Dec 30, 2016 Over the last several years, investors in Antares Pharma  have experienced multiple disappointments which prompted many shareholders to exit the shares while remaining holders became increasingly impatient, illustrated in the chart below&nbsp;...'
p5
aS'Antares Pharma reports 4Q loss Yahoo Finance - Mar 14, 2017 EWING, N.J.  _ Antares Pharma Inc.  on Tuesday reported a loss of $4.5 million in its fourth quarter. On a per-share basis, the Ewing, New Jersey-based company said it had a loss of 3 cents.Antares Pharma Posts Narrower Loss In Q4 - Quick Facts - Nasdaq'
p6
aS'Does Zero-Debt Really Make Antares Pharma Inc  A Financially Strong Company? Simply Wall St - Mar 6, 2017 Any company, including Antares Pharma Inc  with no debt in its capital structure, would maximize capital returns by having an optimal capital structure, which includes debt.ANTARES PHARMA, INC.  Files An 8-K Results of Operations and ... - Market Exclusive'
p7
aS'Looking Mainly At Fundamentals: Antares Pharma, Inc. , OvaScience, Inc ... USA Commerce Daily - Mar 27, 2017 Shares of Antares Pharma, Inc.  are making a strong comeback as they have jumped 294.29% since bottoming out at $0.7 on Mar. 28, 2016.'
p8
aS"Why Investors remained confident on Antares Pharma, Inc. , Canada Goose ... StockNewsJournal - Mar 22, 2017 Investors who are keeping close eye on the stock of Antares Pharma, Inc.  established that the company was able to keep return on investment at - in the trailing twelve month while Reuters data showed that industry's average stands at 12 ..."
p9
aS"Analyst's Indicator Review for MBIA Inc. , Antares Pharma, Inc.  The USA Commerce - Mar 24, 2017 Shares of MBIA Inc.  surged 0.75% to $8.05. During the trading on 03/23/2017, Company's stock ranged from $8.16 to $7.90.New Analyst Ratings On Antares Pharma, Inc.  - NewsDen1-Year Price Target Of Antares Pharma, Inc.  At $3.625 - Enterprise Leader"
p10
a.